Education
About Us
Working with TipRanks
Follow Us
Austar Lifesciences Ltd. (HK:6118)
:6118
6118 Stock Chart & Stats
HK$0.97
-HK$0.02(-3.39%)
At close: 4:00 PM EST
HK$0.97
-HK$0.02(-3.39%)
Day’s Range― - ―
52-Week RangeHK$0.45 - HK$1.97
Previous CloseN/A
Volume4.00K
Average Volume (3M)695.30K
Market Cap
HK$553.59M
Enterprise ValueHK$518.18M
Total Cash (Recent Filing)HK$165.66M
Total Debt (Recent Filing)HK$357.16M
Price to Earnings (P/E)14.6
Beta0.71
Next Earnings
Mar 31, 2026EPS EstimateN/A
Last Dividend Ex-Date
May 19, 2015Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding512,582,030
10 Day Avg. Volume1,360,300
30 Day Avg. Volume695,300
Financial Highlights & Ratios
PEG Ratio-0.15
Price to Book (P/B)0.35
Price to Sales (P/S)0.18
P/FCF Ratio3.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Austar Lifesciences Ltd. News
6118 FAQ
What was Austar Lifesciences Ltd.’s price range in the past 12 months?
Austar Lifesciences Ltd. lowest stock price was HK$0.45 and its highest was HK$1.97 in the past 12 months.
What is Austar Lifesciences Ltd.’s market cap?
Austar Lifesciences Ltd.’s market cap is HK$553.59M.
When is Austar Lifesciences Ltd.’s upcoming earnings report date?
Austar Lifesciences Ltd.’s upcoming earnings report date is Mar 31, 2026 which is in 123 days.
How were Austar Lifesciences Ltd.’s earnings last quarter?
Austar Lifesciences Ltd. released its earnings results on Aug 26, 2025. The company reported HK$0.052 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.052.
Is Austar Lifesciences Ltd. overvalued?
According to Wall Street analysts Austar Lifesciences Ltd.’s price is currently Overvalued.
Does Austar Lifesciences Ltd. pay dividends?
Austar Lifesciences Ltd. pays a Notavailable dividend of HK$0.05 which represents an annual dividend yield of N/A. See more information on Austar Lifesciences Ltd. dividends here
What is Austar Lifesciences Ltd.’s EPS estimate?
Austar Lifesciences Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Austar Lifesciences Ltd. have?
Austar Lifesciences Ltd. has 512,582,030 shares outstanding.
What happened to Austar Lifesciences Ltd.’s price movement after its last earnings report?
Austar Lifesciences Ltd. reported an EPS of HK$0.052 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.758%.
Which hedge fund is a major shareholder of Austar Lifesciences Ltd.?
Currently, no hedge funds are holding shares in HK:6118
Austar Lifesciences Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
52.50%
12-Months-Change
Fundamentals
Return on Equity
4.40%
Trailing 12-Months
Asset Growth
-3.22%
Trailing 12-Months
Company Description
Austar Lifesciences Ltd.
Austar Lifesciences Ltd. (6118) is a biotechnology company based in Australia, specializing in the development and commercialization of innovative therapeutic solutions for various medical conditions. The company operates primarily in the life sciences sector, focusing on drug discovery and development, with a strong emphasis on biologics and novel drug delivery systems. Its core products include proprietary pharmaceutical formulations and technologies aimed at enhancing treatment efficacy and patient outcomes.
Technical Analysis
Vincent Medical Holdings Limited
―
Suzhou Basecare Medical Corp. Ltd. Class H
―
Broncus Holding Corp.
―
Yestar Healthcare Holdings Co Ltd
―
Venus Medtech (Hangzhou), Inc. Class H
―